Results 151 to 160 of about 45,216 (237)

Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells

, 2014
Dali Zhao, Bo Zhai, Changjun He, Gang Tan, Xian Jiang, Shangha Pan, Xuesong Dong, Zheng Wei, Lixin Ma, Haiquan Qiao, Hongchi Jiang, Xueying Sun   +11 more
openalex   +1 more source

KCNQ1OT1 contributes to sorafenib resistance and programmed death‑ligand‑1‑mediated immune escape via sponging miR‑506 in hepatocellular carcinoma cells

, 2020
Junli Zhang, Xiaohui Zhao, Xiaojuan Ma, Zengyan Yuan, Miao Hu   +4 more
openalex   +2 more sources

In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis [PDF]

, 2017
Francesca Fornari, Daniela Pollutri, Clarissa Patrizi, Tiziana La Bella, Sara Marinelli, Andrea Casadei‐Gardini, Giorgia Marisi, Marco Baron Toaldo, Michele Baglioni, Veronica Salvatore, Elisa Callegari, Maurizio Baldassarre, Marzia Galassi, Catia Giovannini, Matteo Cescon, Matteo Ravaioli, Massimo Negrini, Luigi Bolondi, Laura Gramantieri   +18 more
openalex   +1 more source

Microvesicles: the functional mediators in sorafenib resistance

, 2022
Cong He, Doulathunnisa Jaffar Ali, Bo Sun, Beicheng Sun, Zhongdang Xiao   +4 more
openalex   +2 more sources

Supplementary Figure 3 from Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma

, 2023
Bo Zhai, Fengli Hu, Xian Jiang, Jun Xu, Dali Zhao, Bing Liu, Shangha Pan, Xuesong Dong, Gang Tan, Wei Zheng, Haiquan Qiao, Hongchi Jiang, Xueying Sun   +12 more
openalex   +1 more source

Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1)

Journal of Hepatocellular Carcinoma
Srinivas Chava,1 Nergiz Ekmen,2 Pauline Ferraris,1 Yucel Aydin,2 Krzysztof Moroz,1 Tong Wu,1 Swan N Thung,3 Srikanta Dash1,2,4 1Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA; 2Department ...
Chava S, Ekmen N, Ferraris P, Aydin Y, Moroz K, Wu T, Thung SN, Dash S   +7 more
doaj  

MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma [PDF]

, 2021
Peng Xia, Hao Zhang, Kequan Xu, Xiang Jiang, Meng Gao, Ganggang Wang, Yingyi Liu, Ye Yao, Xi Chen, Weijie Ma, Zhonglin Zhang, Yufeng Yuan   +11 more
openalex   +1 more source

LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells

, 2018
Yan Chen, Qing‐Lei Zeng, Xiufang Liu, Junliang Fu, Zhen Zeng, Zhiqin Zhao, Ze Liu, Wenlin Bai, Zheng Dong, Hongjin Liu, Xiaoxia Lü, Yunfeng Zhu, Yinying Lu   +12 more
openalex   +2 more sources

Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance

, 2021
Wei Zhao, Bo Ma, Zhihua Tian, Haibo Han, Jintian Tang, Bin Dong, Guo An, Baoshan Cao, Boqing Wang   +8 more
openalex   +1 more source

Long noncoding RNA DDX11-AS1 represses sorafenib-induced ferroptosis in hepatocellular carcinoma cells via Nrf2-Keap1 pathway

Discover Oncology
Sorafenib, a first-line therapeutic option for advanced hepatocellular carcinoma (HCC), faces a formidable challenge in the form of emerging resistance.
Liang Wang, Liming Wang
doaj   +1 more source